Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
36,035,033
-
Share change
-
+6,530,234
-
Total reported value
-
$2,613,664,389
-
Put/Call ratio
-
91%
-
Price per share
-
$72.49
-
Number of holders
-
140
-
Value change
-
+$445,184,584
-
Number of buys
-
95
-
Number of sells
-
57
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2021
As of 30 Sep 2021,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,035,033 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, Cederberg Capital Ltd, BlackRock Inc., Zeal Asset Management Ltd, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, PICTET ASSET MANAGEMENT SA, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
140
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.